Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: a single-institution matched-pair analysis

J Liu, Z Zhang, H Huang, S Xu, Y Liu, S Liu, X Wang… - Oral Oncology, 2019 - Elsevier
Background Total thyroidectomy (TT) is recommended by guidelines for intermediate-risk
papillary thyroid carcinoma (PTC) but its survival advantage over lobectomy has not been …

Outcomes of patients with an intermediate-risk group according to the Japanese risk classification of papillary thyroid carcinoma

K Horiuchi, M Fujimoto, K Hidenori, Y Yoshida… - World Journal of …, 2023 - Springer
Background The management of intermediate-risk group of papillary thyroid cancer (PTC) is
still vague, particularly regarding whether or not total thyroidectomy, postoperative …

Dynamic risk assessment in patients with differentiated thyroid cancer

E Abelleira, F Jerkovich - Reviews in Endocrine and Metabolic Disorders, 2024 - Springer
The current approach for patients with differentiated thyroid carcinoma should be
individualized according to the risk of recurrence, and this stratification could be used to …

Transoral endoscopic thyroidectomy by vestibular approach with central lymph node dissection for thyroid microcarcinoma

HX Nguyen, HX Nguyen, HV Nguyen… - … & Advanced Surgical …, 2021 - liebertpub.com
Background: The transoral endoscopic thyroidectomy by vestibular approach (TOETVA) has
been developed for thyroid microcarcinoma (TMC) treatment worldwide, with low rate of …

Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low-and Intermediate-Risk DTC Patients

F Maino, M Botte, C Dalmiglio, L Valerio… - The Journal of …, 2024 - academic.oup.com
Abstract Context American Thyroid Association (ATA) guidelines do not consider age at
diagnosis as a prognostic factor on the estimation of the risk of persistent/recurrent disease …

[引用][C] 《 2015 美国甲状腺学会成人甲状腺结节与分化型甲状腺癌诊治指南》 外科治疗更新解读

兰霞斌, 张浩 - 中华外科杂志, 2016

The SIRT6-autophagy-warburg effect axis in papillary thyroid cancer

Z Yang, R Huang, X Wei, W Yu, Z Min, M Ye - Frontiers in Oncology, 2020 - frontiersin.org
As shown in our previous study, SIRT6 promotes an aggressive phenotype and the
epithelial-mesenchymal transition (EMT) in papillary thyroid cancer (PTC). In this study, we …

[HTML][HTML] Current controversies and future directions in the diagnosis and management of differentiated thyroid cancers

TM Ullmann, KD Gray, MD Moore, R Zarnegar… - Gland …, 2018 - ncbi.nlm.nih.gov
Despite the development of novel diagnostic, surgical, and chemotherapeutic approaches to
differentiated thyroid cancers (DTCs), the diagnosis and management of these tumors …

Lobectomy is a more cost-effective option than total thyroidectomy for 1 to 4 cm papillary thyroid carcinoma that do not possess clinically recognizable high-risk …

BHH Lang, CKH Wong - Annals of surgical oncology, 2016 - Springer
Background Although lobectomy is a viable alternative to total thyroidectomy (TT) in low-risk
1 to 4 cm papillary thyroid carcinoma (PTC), lobectomy is associated with higher …

Thyroid lobectomy for low to intermediate risk differentiated thyroid cancer

DM Hartl, J Guerlain, I Breuskin, J Hadoux, E Baudin… - Cancers, 2020 - mdpi.com
Simple Summary Total thyroidectomy used to be recommended for all thyroid cancers. We
now know that some thyroid cancers have a relatively low risk of recurrence. Today, for …